Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy.
10.3346/jkms.2018.33.e306
- Author:
Hwallip BAE
1
;
Daeho KIM
;
Yubin CHO
;
Dongjoo KIM
;
Seok Hyeon KIM
Author Information
1. Workplace Mental Health Institute, Gangbuk Samsung Medical Center, Seoul, Korea.
- Publication Type:Brief Communication
- Keywords:
PTSD;
Drug Therapy;
Antidepressants;
EMDR
- MeSH:
Adult*;
Antidepressive Agents;
Drug Therapy*;
Eye Movement Desensitization Reprocessing;
Eye Movements*;
Follow-Up Studies;
Humans;
Stress Disorders, Post-Traumatic*
- From:Journal of Korean Medical Science
2018;33(48):e306-
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study examined the add-on efficacy of eye movement desensitization and reprocessing (EMDR) therapy among adult civilians with post-traumatic stress disorder (PTSD) who continued to be symptomatic after more than 12 weeks of initial antidepressant treatment. Scores for the Clinician Administered PTSD Scale (CAPS) were rated pre- and post-EMDR and at a 6-month follow-up. After an average of six sessions of EMDR treatment, seven of 14 patients (50%) showed more than a 30% decrease in CAPS score and eight (57%) no longer met the criteria for PTSD. Our results indicate that EMDR could be successfully added after failure of initial pharmacotherapy for PTSD.
